Trial intelligence / Profile preview

Testosterone Therapy in Hip Replacement

NCT05722301Phase 3Withdrawn

Sponsor
American Hip Institute
Start
Nov 2019
Primary completion
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of testosterone in testosterone deficiency (TD), sponsored by American Hip Institute. Planned start Nov 2019; status: withdrawn.

02

Drugs

testosterone
03

Conditions

testosterone deficiency (TD)

Beyond the preview

Go deeper on NCT05722301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05722301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call